Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

ALL # A B C D E F G H I K L M N O P Q R S T U V W Z

Clear all filters

Displaying 19 projects and 1 programmes

DRIVE

Development of Robust and Innovative Vaccine Effectiveness

EBODAC

Communication strategy and tools for optimizing the impact of Ebola vaccination deployment

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Tools for predicting/monitoring efficacy

Ebola+

Ebola and other filoviral haemorrhagic fevers

Ongoing IMI2 Infectious diseases Ebola and related diseases Vaccines Diagnostics Ebola+ Manufacturing technologies

EBOMAN

Manufacturing and development for rapid access Ebola vaccine

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Manufacturing technologies

EBOVAC1

Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Clinical trial design Conducting clinical trials

EBOVAC2

Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Conducting clinical trials

EBOVAC3

Bringing a prophylactic Ebola vaccine to licensure

Ongoing IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Conducting clinical trials

iCONSENSUS

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

Closed IMI2 Vaccines Biologicals Manufacturing technologies

Inno4Vac

Innovations to accelerate vaccine development and manufacture

Ongoing IMI2 Infectious diseases Vaccines Tools for predicting/monitoring efficacy Big data and knowledge management Artificial intelligence

PERISCOPE

PERtussIS COrrelates of Protection Europe

Closed IMI2 Infectious diseases Vaccines Conducting clinical trials

PEVIA

Pan Ebola vaccine innovative approach

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+

PRIMAVERA

Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance

Ongoing IMI2 Antimicrobial resistance Infectious diseases Vaccines Biologicals AMR Accelerator Economic model

VAC2VAC

Vaccine lot to vaccine lot comparison by consistency testing

Closed IMI2 Infectious diseases Vaccines 3Rs - animal use in research Regulatory and HTA processes

VITAL

Vaccines and infectious diseases in the ageing population

Ongoing IMI2 Ageing-associated diseases Infectious diseases Vaccines Tools for predicting/monitoring efficacy Real-world data, evidence

VSV-EBOPLUS

Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+ Tools for predicting/monitoring efficacy

VSV-EBOVAC

Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV

Closed IMI2 Infectious diseases Ebola and related diseases Vaccines Ebola+

ADVANCE

Accelerated development of vaccine benefit-risk collaboration in Europe

Closed IMI1 Infectious diseases Vaccines Methods for benefit/risk assessment

BioVacSafe

Biomarkers for Enhanced Vaccine Immunosafety

Closed IMI1 Infectious diseases Vaccines Tools for predicting/monitoring efficacy

FLUCOP

Standardization and development of assays for assessment of influenza vaccines correlates of protection

Closed IMI1 Respiratory diseases Infectious diseases Vaccines

ZAPI

Zoonotic anticipation and preparedness initiative

Closed IMI1 Infectious diseases Vaccines